GlassScriptPhysician profile
Hamid Feroze
NPI 1568425395
$4,290.70
in general payments reported to CMS, 2019-2025
22 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $444 · 2021: $405 · 2022: $340 · 2023: $2,063 · 2024: $328 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580 · Travel and Lodging: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.40 |
| Travel and Lodging | $1,094.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,640.53 | 2023 | Venaseal, Micra |
| Pfizer INC. | $435.59 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $390.30 | 2021-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $343.56 | 2019-2024 | |
| Boston Scientific Corporation | $230.30 | 2019-2024 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.01 | 2019-2025 | Lifevest |
| Abbott Laboratories | $198.51 | 2020-2023 | Assurity |
| Janssen Pharmaceuticals, INC | $183.41 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $132.30 | 2019-2023 | Camzyos |
| Merck Sharp & Dohme LLC | $89.00 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $72.62 | 2021-2024 | Farxiga |
| Surmodics, INC. | $67.40 | 2023 | Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Amgen INC. | $61.51 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.05 | 2025 | |
| Olympus America INC. | $40.00 | 2025 | Olympus, Hd Camera Head |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $27.57 | 2022 | |
| Abiomed | $22.87 | 2025 | |
| Sanofi-Aventis U.S. LLC | $22.67 | 2019 | |
| Novo Nordisk INC | $20.88 | 2025 | Ozempic |
| Actelion Pharmaceuticals US, INC. | $16.88 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.55 | 2019 | |
| Shockwave Medical, INC | $14.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Feroze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.